Agilent Technologies Inc Cash Flow Conversion Efficiency

Latest as of July 2025: 0.057x

Agilent Technologies Inc cash flow conversion efficiency. Based on the latest financial reports, Agilent Technologies Inc (A) has a cash flow conversion efficiency ratio of 0.057x as of July 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($362.00 Million) by net assets ($6.37 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Agilent Technologies Inc (1998–2025)

Cash flow conversion efficiency of Agilent Technologies Inc from 1998 to 2025. This chart illustrates how Agilent Technologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Agilent Technologies Inc for real-time trading data and today's change.

Agilent Technologies Inc Cash Flow Conversion Ratio Explained

Agilent Technologies Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Agilent Technologies Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Agilent Technologies Inc ranked by their cash flow conversion efficiency. Also see A company net worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Humana Inc
NYSE:HUM
-0.022x
MSCI Inc
NYSE:MSCI
-0.111x
Ferguson Plc
NYSE:FERG
0.131x
DR Horton Inc
NYSE:DHI
0.035x
Coca-Cola European Partners PLC
NASDAQ:CCEP
0.116x
Takeda Pharmaceutical Company Limited
F:TKDA
0.049x
East Money Information Co Ltd
SHE:300059
-0.037x
STANDARD CHART.UNSP.ADR/2
F:STD0
N/A

Annual Cash Flow Conversion Efficiency for Agilent Technologies Inc (1998–2025)

The table below shows the annual cash flow conversion efficiency of Agilent Technologies Inc from 1998 to 2025. Review free cash flow generation of Agilent Technologies Inc to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-10-31 $6.74 Billion $1.56 Billion 0.231x -22.10%
2024-10-31 $5.90 Billion $1.75 Billion 0.297x -2.07%
2023-10-31 $5.84 Billion $1.77 Billion 0.303x +22.58%
2022-10-31 $5.30 Billion $1.31 Billion 0.247x -10.25%
2021-10-31 $5.39 Billion $1.49 Billion 0.276x +45.80%
2020-10-31 $4.87 Billion $921.00 Million 0.189x -12.11%
2019-10-31 $4.75 Billion $1.02 Billion 0.215x -9.57%
2018-10-31 $4.57 Billion $1.09 Billion 0.238x +29.33%
2017-10-31 $4.83 Billion $889.00 Million 0.184x -1.60%
2016-10-31 $4.24 Billion $793.00 Million 0.187x -41.23%
2015-10-31 $4.16 Billion $1.32 Billion 0.318x +135.76%
2014-10-31 $5.29 Billion $713.00 Million 0.135x -38.08%
2013-10-31 $5.29 Billion $1.15 Billion 0.218x -8.03%
2012-10-31 $5.18 Billion $1.23 Billion 0.237x -18.87%
2011-10-31 $4.32 Billion $1.26 Billion 0.292x +32.68%
2010-10-31 $3.24 Billion $712.00 Million 0.220x +35.14%
2009-10-31 $2.51 Billion $408.00 Million 0.163x -44.89%
2008-10-31 $2.56 Billion $756.00 Million 0.295x -1.40%
2007-10-31 $3.23 Billion $969.00 Million 0.300x +72.92%
2006-10-31 $3.66 Billion $634.00 Million 0.173x -21.34%
2005-10-31 $4.08 Billion $899.00 Million 0.220x +17.35%
2004-10-31 $3.57 Billion $670.00 Million 0.188x +468.15%
2003-10-31 $2.82 Billion $-144.00 Million -0.051x +52.62%
2002-10-31 $4.63 Billion $-498.00 Million -0.108x -140.55%
2001-10-31 $5.66 Billion $1.50 Billion 0.265x +66.76%
2000-10-31 $5.26 Billion $838.00 Million 0.159x +16.77%
1999-10-31 $3.38 Billion $461.00 Million 0.136x -45.15%
1998-10-31 $3.02 Billion $751.00 Million 0.249x --

About Agilent Technologies Inc

NYSE:A USA Diagnostics & Research
Market Cap
$49.47 Billion
Market Cap Rank
#607 Global
#297 in USA
Share Price
$174.76
Change (1 day)
+1.73%
52-Week Range
$110.24 - $181.48
All Time High
$181.48
About

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrome… Read more